These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6322388)

  • 1. Morphologic evidence for vaginal toxicity of Delfen contraceptive cream in the rat.
    Tryphonas L; Buttar HS
    Toxicol Lett; 1984 Mar; 20(3):289-95. PubMed ID: 6322388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teratology study of intravaginally administered nonoxynol-9-containing contraceptive cream in rats.
    Abrutyn D; McKenzie BE; Nadaskay N
    Fertil Steril; 1982 Jan; 37(1):113-7. PubMed ID: 6277696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the spermicide nonoxynol-9 on the pregnant uterus and the conceptus of rat.
    Tryphonas L; Buttar HS
    Toxicology; 1986 May; 39(2):177-86. PubMed ID: 3010506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Patentex-Oval - an intravaginal contraceptive agent].
    Horoszko-Husiatyńska B; Peterek J; Bednarz J
    Wiad Lek; 1981 Jun; 34(12):985-9. PubMed ID: 6272498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a new vaginal contraceptive.
    Stone SC; Cardinale F
    Am J Obstet Gynecol; 1979 Mar; 133(6):635-8. PubMed ID: 233541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primate model for the evaluation of vaginal contraceptives.
    Zaneveld LJ; Bhattacharyya AK; Kim DS; Schumacher GF; Beluhan Z
    Am J Obstet Gynecol; 1977 Oct; 129(4):368-73. PubMed ID: 410295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive murine model to evaluate topical vaginal microbicides: mucosal inflammation and susceptibility to genital herpes as surrogate markers of safety.
    Galen BT; Martin AP; Hazrati E; Garin A; Guzman E; Wilson SS; Porter DD; Lira SA; Keller MJ; Herold BC
    J Infect Dis; 2007 May; 195(9):1332-9. PubMed ID: 17397004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental vaginitis in rats].
    Haring J; Aurousseau M; Adnet JJ
    Bull Assoc Anat (Nancy); 1985 Dec; 69(207):343-9. PubMed ID: 3030469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary results, serum chemistry values before and after the intravaginal administration of 5% nonoxynol-9 cream.
    Malyk B
    Fertil Steril; 1981 Jun; 35(6):647-52. PubMed ID: 6113993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genital tract toxicity of nonoxynol-9 in female rats: temporal development, reversibility and sequelae of the induced lesions.
    Tryphonas L; Buttar HS
    Fundam Appl Toxicol; 1982; 2(5):211-9. PubMed ID: 6309594
    [No Abstract]   [Full Text] [Related]  

  • 11. An intravaginal contraceptive device for the delivery of an acrosin and hyaluronidase inhibitor.
    Burck PJ; Zimmerman RE
    Fertil Steril; 1984 Feb; 41(2):314-8. PubMed ID: 6365601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the action of nonoxynol-9 and chlorhexidine on sperm.
    Sharman D; Chantler E; Dukes M; Hutchinson FG; Elstein M
    Fertil Steril; 1986 Feb; 45(2):259-64. PubMed ID: 3005050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe chemical cystitis from the transurethral intravesical insertion of a vaginal contraceptive suppository: a report of 3 cases and proposed method of management.
    Mayersak JS; Viviano CJ
    J Urol; 1993 Apr; 149(4):835-7. PubMed ID: 8384272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the cytotoxicity and genotoxicity of the spermicides nonoxynol-9 and octoxynol-9.
    Buttar HS; Swierenga SH; Matula TI
    Toxicol Lett; 1986 Apr; 31(1):65-73. PubMed ID: 3012825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GM-144, a novel lipophilic vaginal contraceptive gel-microemulsion.
    D'Cruz OJ; Yiv SH; Uckun FM
    AAPS PharmSciTech; 2001 Apr; 2(2):E5. PubMed ID: 14727880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration of a spirocheticidal effect by chemical contraceptives on Treponema pallidum.
    Singh B; Cutler JC
    Bull Pan Am Health Organ; 1982; 16(1):59-64. PubMed ID: 7042017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical effectiveness of a new vaginal contraceptive cream: a preliminary report.
    Behne D; Clark F; Jennings M; Pallais V; Olson H; Wolf L; Tyler ET
    West J Surg Obstet Gynecol; 1956 Mar; 64():152-7. PubMed ID: 12233283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes.
    Kreiss J; Ngugi E; Holmes K; Ndinya-Achola J; Waiyaki P; Roberts PL; Ruminjo I; Sajabi R; Kimata J; Fleming TR
    JAMA; 1992 Jul 22-29; 268(4):477-82. PubMed ID: 1320133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the intravaginal insert (IVI): acceptability, side effects, and post-coital spermicidal activity.
    Ahmad M; Asch RH
    Acta Eur Fertil; 1984; 15(5):369-76. PubMed ID: 6099026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spermicides, HIV, and the vaginal sponge.
    Stone KM; Peterson HB
    JAMA; 1992 Jul 22-29; 268(4):521-3. PubMed ID: 1320135
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.